Trends in study design and the statistical methods employed in a leading general medicine journal

Journal of Clinical Pharmacy and Therapeutics

Volumn 43, Issue 1, 2018, Pages 36-44

  Gosho, M ^a   Sato, Y ^b   Nagashima, K ^b   Takahashi, S ^c  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

adaptive design; interventional study; missing data; New England Journal of Medicine; observational study

Indexed keywords

CLINICAL TRIAL; DATA BASE; GENERAL PRACTICE; HUMAN; INTERVENTION STUDY; KAPLAN MEIER METHOD; MEDICAL LITERATURE; OBSERVATIONAL STUDY; PROPORTIONAL HAZARDS MODEL; PUBLICATION; SAMPLE SIZE; STUDY DESIGN; UNITED STATES; EVIDENCE BASED MEDICINE; MEDICAL RESEARCH; METHODOLOGY; STATISTICAL ANALYSIS; STATISTICAL MODEL; TRENDS;

BIOMEDICAL RESEARCH; DATA INTERPRETATION, STATISTICAL; EVIDENCE-BASED MEDICINE; HUMANS; MODELS, STATISTICAL; PUBLICATIONS; RESEARCH DESIGN;

EID: 85026356508     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12605     Document Type: Article

References (29)

1. Little RJ, D'Agostino R, Cohen ML, et al. The prevention and treatment of missing data in clinical trials. N Engl J Med. 2012;367:1355-1360.
2. U.S. Department of Health and Human Services, Food and Drug Administration. Guidance for Industry. Adaptive Design Clinical Trials for Drugs and Biologics. Draft Guidance. https://www.fda.gov/downloads/Drugs/../Guidances/UCM201790.pdf (2010, accessed 15 May 2017).
3. Hayden GF. Biostatistical trends in pediatrics: implications for the future. Pediatrics. 1983;72:84-87.
4. Schwartz SJ, Sturr M, Goldberg G. Statistical methods in rehabilitation literature: a survey of recent publications. Arch Phys Med Rehabil. 1996;77:497-500.
5. Goldin J, Zhu W, Sayre JW. A review of the statistical analysis used in papers published in Clinical Radiology and British Journal of Radiology. Clin Radiol. 1996;51:47-50.
6. Olsen CH. Review of the use of statistics in infection and immunity. Infect Immun. 2003;71:6689-6692.
7. Kurichi JE, Sonnad SS. Statistical methods in the surgical literature. J Am Coll Surg. 2006;202:476-484.
8. Rigby AS, Armstrong GK, Campbell M, et al. A survey of statistics in three UK general practice journal. BMC Med Res Methodol. 2004;4:28.
9. Rao MH, Khan N. Comparison of statistical methods, type of articles and study design used in selected Pakistani medical journals in 1998 and 2007. J Pak Med Assoc. 2010;60:745-750.
10. Emerson JD, Colditz GA. Use of statistical analysis in the New England Journal of Medicine. N Engl J Med. 1983;309:709-713.
11. Horton NJ, Switzer SS. Statistical methods in the journal. N Engl J Med. 2005;353:1977-1979.
12. Sato Y, Gosho M, Nagashima K, et al. Statistical methods in the journal – an update. N Engl J Med. 2017;376:1086-1087.
13. Zhang JZ, Zhang XF, Huang SJ, et al. Long-term efficacy of a hepatitis E vaccine. N Engl J Med. 2015;372:914-922.
14. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010;152:726-732.
15. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-1154.
16. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
17. Molenberghs G, Fitzmaurice G, Kenward MG, et al. Handbook of missing data methodology. Boca Raton: Chapman & Hall/CRC; 2014:507.
18. Burton A, Altman DG. Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines. Br J Cancer. 2004;91:4-8.
19. Horton NJ, Kleinman KP. Much ado about nothing: a comparison of missing data methods and software to fit incomplete data regression models. Am Stat. 2007;61:79-90.
20. International Conference on Harmonization. Statistical principles for clinical trials (ICH E-9). http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E9/Step4/E9_Guideline.pdf (1998, accessed 15 May 2017).
21. O'Brien PC, Fleming TR. A Multiple testing procedure for clinical trials. Biometrics. 1979;35:549-556.
22. Lan KG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika. 1983;70:659-663.
23. Hartung J. Flexible designs by adaptive plans of generalized Pocock-and O'Brien-Fleming-type and by self-designing clinical trials. Biom J. 2006;48:521-536.
24. Brittain EH, Bailey KR. Optimization of multistage testing times and critical values in clinical trials. Biometrics. 1993;49:763-772.
25. Committee for Medical Products for Human Use. Guideline on missing data in confirmatory clinical trials. London: European Medicines Evaluation Agency. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/09/WC500096793.pdf (2010, accessed 19 June 2017).
26. National Research Council. The prevention and treatment of missing data in clinical trials. Washington, DC: The National Academies Press, 2010.
27. Chavalarias D, Wallach JD, Li AHT, et al. Evolution of reporting P values in the biomedical literature, 1990-2015. J Am Med Assoc. 2016;315:1141-1148.
28. Wasserstein RL, Lazar NA. The ASA's statement on P-values: context, process, and purpose. Am Stat. 2016;70:129-133.
29. Bailar JC, Mosteller F. Guidelines for statistical reporting in articles for medical journals: amplifications and explanations. Ann Intern Med. 1988;108:266-273.